Neuroinflammation During ICU-associated Delirium in Critically Ill Patients and Its Association With Structural and Functional Brain Alterations: a Nested Case-control Study
NCT ID: NCT04078503
Last Updated: 2019-09-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2019-03-25
2021-06-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Peripheral Inflammation and Brain Structural Alterations in Patients With Disorders of Consciousness.
NCT03908541
Psychometric Evaluation in Patients With Brain Damage During Neuroinflammation
NCT05450237
Prognostication of Recovery in Early Disorders of Consciousness Study
NCT07074678
REsting and Stimulus-based Paradigms to Detect Organized NetworkS and Predict Emergence of Consciousness
NCT03504709
Prognostication of Recovery in Early Disorders of Consciousness Study
NCT04692922
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The authors want to clarify the role of the alterations of different cellular components of neuroinflammation (neurons, glial cells, and endothelium) in delirium development. Moreover, the authors want to understand whether the neuroinflammation process could cause permanent structural and functional brain damage.
In a nested cross-sectional longitudinal case-control observational study in ICU admitted patients.
The objectives of the studies are as follow: 1) Neuroinflammation biomarkers evaluation in non-neurological ICU patients who develop delirium during ICU-stay (case) compared to matched non-delirious ICU patients (control), and 2) their correlation with brain structural and functional alterations evaluated with a resting-state fMRI protocol and PET.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case
All patients aspected to stay in ICU for at least 3 days who will develop delirium
No interventions assigned to this group
Control
All patients aspected to stay in ICU for at least 3 days who will not develop delirium (1:1 matched with the controls with a propensity score method).
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All patients admitted that would be expected to stay in ICU for at least 3 days
Exclusion Criteria
* Chronic neurological condition (i.e., seizures, stroke, muscular illness).
* Hematological malignancy or immunological disease.
* Blood transfusion in the last 2 weeks
* Ongoing sedation
* Any condition which contraindicates MRI execution (presence of non-compatible devices or hemodynamic or respiratory instability).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pisa
OTHER
University of Turin, Italy
OTHER
University of Milano Bicocca
OTHER
Università degli Studi di Brescia
OTHER
Mie University
OTHER
Erasme University Hospital
OTHER
Maastricht University
OTHER
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Piva Simone
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Spedali Civili di Brescia
Brescia, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NP3468
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.